Marion Emilie Genevieve Brunck serves as a Researcher at Tecnológico de Monterrey's School of Engineering within the Department of Biotechnology, where she leads the Biotechnology Center-FEMSA. Her laboratory focuses on immune cell function mechanisms with applications in immunomodulation and therapeutic development. Bachelor of Science, The University of Queensland Brisbane Doctor of Philosophy in Immunology and Systems Biology, The University of Queensland Brisbane (2015) Dr. Brunck's research integrates immunology, systems biology, and biotechnology to investigate endogenous/exogenous triggers modifying immune cell phenotypes. Her work spans neutrophil biology, obesity-related immunomodulation, maternal-fetal immunity, and therapeutic cell platform development. The laboratory employs OMICS methodologies, flow cytometry (including BD FACSCelesta), and synthetic biology approaches to study immune cell progenitors and their applications. Her 15 most recent publications demonstrate strong focus on immunometabolism, maternal-child immunology, and translational immunotherapies. Key trends include investigating leukocyte dynamics in breastmilk, macrophage metabolism in cardiometabolic disease, and neutrophil engineering for therapeutic applications. Research spans basic immunology through clinical applications with emphasis on Latin American health contexts. Competitive Research Scholarship from Stem Cells Australia Mexican Researcher Certification - Level 2 Dr. Brunck actively mentors through TEC's School of Engineering postgraduate society (Rho Factor) and SACBE STEM, promoting women in science. She supervises 4 MSc and 2 PhD students in the Brunck Lab, which maintains comprehensive immunology research infrastructure. Her collaborative work includes partnerships with the Mexican Society of Immunology and Mexican Society for Biotechnology and Bioengineering. The Brunck Lab operates within the Biotechnology Center-FEMSA at Campus Monterrey, equipped with BD FACSCelesta flow cytometer, biosafety hoods, incubators, and molecular biology equipment. Her team investigates immune cell phenotypic modifications for therapeutic applications while contributing to public science education through the American Association of Blood Banks and STEM outreach initiatives.

